Development and Validation of a Scoring System, Based on Genetic and Clinical Factors, to Determine Risk of Steatohepatitis in Asian Patients with Nonalcoholic Fatty Liver Disease-Reference-Cited by-同舟云学术

Development and Validation of a Scoring System, Based on Genetic and Clinical Factors, to Determine Risk of Steatohepatitis in Asian Patients with Nonalcoholic Fatty Liver Disease

Published:2020-10 Issue:11 Volume:18 Page:2592-2599.e10
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Koo Bo Kyung^ORCID,Joo Sae Kyung^ORCID,Kim Donghee,Lee Seonhwa,Bae Jeong Mo,Park Jeong Hwan,Kim Jung Ho,Chang Mee Soo^ORCID,Kim Won^ORCID

Funder

National Research Foundation of Korea

MEST

Korea Health Industry Development Institute

Ministry of Health

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference49 articles.

1. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States;Wong;Gastroenterology,2015

2. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis;Sanyal;N Engl J Med,2010

3. Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study;Armstrong;Lancet,2016

4. Elafibranor, an agonist of the peroxisome proliferator-activated receptor-alpha and -delta, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening;Ratziu;Gastroenterology,2016

5. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease;J Hepatol,2016

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Are we ready for genetic testing in metabolic dysfunction‐associated steatotic liver disease?;United European Gastroenterology Journal;2024-04-24

2. Nonalcoholic fatty liver disease: What comes before and what are the consequences?;Chronic Complications of Diabetes Mellitus;2024

3. Anlotinib Attenuates Liver Fibrosis by Regulating the Transforming Growth Factor β1/Smad3 Signaling Pathway;Digestive Diseases and Sciences;2023-09-08

4. MBOAT7 rs641738 Variant Is Not Associated with an Increased Risk of Hepatocellular Carcinoma in a Latin American Cohort;Digestive Diseases and Sciences;2023-09-08

5. MBOAT7 rs641738 (C>T) is associated with NAFLD progression in men and decreased ASCVD risk in elder Chinese population;Frontiers in Endocrinology;2023-06-22